z-logo
open-access-imgOpen Access
Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction
Author(s) -
Michael A. Bellio,
Rosemeire M. KanashiroTakeuchi,
Lauro M Takeuchi,
Shathiyah Kulandavelu,
Young Soon Lee,
Wayne Balkan,
Karen Young,
Joshua M. Hare,
Aisha Khan
Publication year - 2022
Publication title -
the journal of cardiovascular aging
Language(s) - English
Resource type - Journals
ISSN - 2768-5993
DOI - 10.20517/jca.2021.21
Subject(s) - wharton's jelly , mesenchymal stem cell , extracellular vesicles , myocardial infarction , cardiac function curve , vesicle , function (biology) , microvesicles , chemistry , cardiology , microbiology and biotechnology , medicine , biology , heart failure , biochemistry , microrna , membrane , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here